AEYE-DS
JSON twin: https://www.healthaidb.com/software/aeye-ds.json
Company Name
AEYE Health
Product URL
https://www.aeyehealth.com/aeye-diagnostic-screening
Company URL
https://www.aeyehealth.com
Categories
Summary
AEYE-DS is an AI-powered diagnostic screening solution for diabetic retinopathy, enabling rapid, point-of-care detection using portable retinal cameras.
Description
AEYE-DS, developed by AEYE Health, is an FDA-cleared AI diagnostic system designed for autonomous detection of more-than-mild diabetic retinopathy in adults with diabetes. It operates with portable retinal cameras, requiring only one image per eye and rarely necessitating dilation, providing instant diagnostic results. The system is compatible with Topcon NW400 and Optomed Aurora cameras, facilitating flexible and accessible screening in various healthcare settings. AEYE-DS has demonstrated high sensitivity and specificity in clinical studies, with sensitivity ranging from 92% to 93% and specificity between 89% and 94%, depending on the camera used. The solution is reimbursable under CPT code 92229, addressing care gaps and improving quality metrics such as HEDIS scores and Star ratings. AEYE Health has partnered with organizations like Ford Medical to expand AEYE-DS's availability in pharmacies and non-acute centers, enhancing early detection and treatment of diabetic retinopathy. Additionally, AEYE-DS has been integrated into electronic medical record systems, such as at UMass Memorial Health, to streamline workflows and improve patient outcomes. The system's portability and ease of use make it suitable for home care settings, offering convenient screening options for patients.
Api Available
unknown
Certifications
- FDA 510(k) clearance
- SOC 2 Type II certification
Company Founding
2019
Company Offices
Compliance
- HIPAA
- FDA 510(k) clearance
- SOC 2 Type II certification
Customers
Data Residency
US/EU regions
Data Standards
- FHIR
- HL7 v2
- DICOM
- SNOMED
- ICD-10
Deployment Model
Features
- Autonomous diabetic retinopathy screening
- Single image per eye requirement
- Instantaneous diagnostic results
- Portable and cost-effective retinal cameras
- Integration with electronic medical records (EMR)
- FDA-cleared for use with Topcon NW400 and Optomed Aurora cameras
- High sensitivity and specificity in clinical studies
- Dedicated CPT code 92229 for AI diabetic retinopathy screening
- Improvement in diabetic eye care adherence and quality measures
Id
SW0226
Integration Partners
Integrations
- Topcon NW400
- Optomed Aurora
- Electronic Medical Records (EMR) systems
Languages Supported
Last Updated
2025-10-11
License
commercial
Market Segment
Optional Modules
- Handheld device integration
- Robotic tabletop camera integration
Os Platforms
- Web
- iOS
- Android
- Windows
- macOS
- Linux
Pricing Details
contact vendor
Pricing Model
subscription
Privacy Features
- BAA available
- consent management
- anonymization
- data minimization
Product Code
SW0226
Product Name
AEYE-DS
Ratings
Regions Available
Related Urls
Release Year
Security Features
- Encryption
- RBAC
- SSO/SAML
- audit logs
- 2FA
- DLP
Specialties
Support Channels
System Requirements
Topcon NW400 or Optomed Aurora camera, internet connectivity
Target Users
- clinicians
- nurses
- patients
- admins
- payers
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "AEYE-DS",
"company_name": "AEYE Health",
"product_url": "https://www.aeyehealth.com/aeye-diagnostic-screening",
"company_url": "https://www.aeyehealth.com",
"related_urls": [
"https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
],
"product_code": "SW0226",
"summary": "AEYE-DS is an AI-powered diagnostic screening solution for diabetic retinopathy, enabling rapid, point-of-care detection using portable retinal cameras.",
"description": "AEYE-DS, developed by AEYE Health, is an FDA-cleared AI diagnostic system designed for autonomous detection of more-than-mild diabetic retinopathy in adults with diabetes. It operates with portable retinal cameras, requiring only one image per eye and rarely necessitating dilation, providing instant diagnostic results. The system is compatible with Topcon NW400 and Optomed Aurora cameras, facilitating flexible and accessible screening in various healthcare settings. AEYE-DS has demonstrated high sensitivity and specificity in clinical studies, with sensitivity ranging from 92% to 93% and specificity between 89% and 94%, depending on the camera used. The solution is reimbursable under CPT code 92229, addressing care gaps and improving quality metrics such as HEDIS scores and Star ratings. AEYE Health has partnered with organizations like Ford Medical to expand AEYE-DS's availability in pharmacies and non-acute centers, enhancing early detection and treatment of diabetic retinopathy. Additionally, AEYE-DS has been integrated into electronic medical record systems, such as at UMass Memorial Health, to streamline workflows and improve patient outcomes. The system's portability and ease of use make it suitable for home care settings, offering convenient screening options for patients.",
"categories": [
"diagnostic Support",
"clinical Care",
"patient Facing",
"administrative Operations",
"Diagnostic",
"Clinical",
"Patient-facing",
"Administrative"
],
"market_segment": [
"enterprise",
"smb",
"consumer"
],
"target_users": [
"clinicians",
"nurses",
"patients",
"admins",
"payers"
],
"specialties": [
"Diabetic Retinopathy",
"Ophthalmology"
],
"regions_available": [
"United States"
],
"languages_supported": [
"English"
],
"pricing_model": "subscription",
"pricing_details": "contact vendor",
"license": "commercial",
"company_offices": [
"United States",
"Israel"
],
"company_founding": "2019",
"deployment_model": [
"SaaS",
"on_prem",
"hybrid"
],
"os_platforms": [
"Web",
"iOS",
"Android",
"Windows",
"macOS",
"Linux"
],
"features": [
"Autonomous diabetic retinopathy screening",
"Single image per eye requirement",
"Instantaneous diagnostic results",
"Portable and cost-effective retinal cameras",
"Integration with electronic medical records (EMR)",
"FDA-cleared for use with Topcon NW400 and Optomed Aurora cameras",
"High sensitivity and specificity in clinical studies",
"Dedicated CPT code 92229 for AI diabetic retinopathy screening",
"Improvement in diabetic eye care adherence and quality measures"
],
"optional_modules": [
"Handheld device integration",
"Robotic tabletop camera integration"
],
"integrations": [
"Topcon NW400",
"Optomed Aurora",
"Electronic Medical Records (EMR) systems"
],
"data_standards": [
"FHIR",
"HL7 v2",
"DICOM",
"SNOMED",
"ICD-10"
],
"api_available": "unknown",
"system_requirements": "Topcon NW400 or Optomed Aurora camera, internet connectivity",
"compliance": [
"HIPAA",
"FDA 510(k) clearance",
"SOC 2 Type II certification"
],
"certifications": [
"FDA 510(k) clearance",
"SOC 2 Type II certification"
],
"security_features": [
"Encryption",
"RBAC",
"SSO/SAML",
"audit logs",
"2FA",
"DLP"
],
"privacy_features": [
"BAA available",
"consent management",
"anonymization",
"data minimization"
],
"data_residency": "US/EU regions",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "",
"integration_partners": [],
"id": "SW0226",
"slug": "aeye-ds",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/aeye-ds.json"
}
}